Related Party Transactions (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 07, 2017 |
Feb. 28, 2017 |
Jan. 31, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
Dec. 31, 2017 |
|
| Exercise price of warrants | $ 0.0038 | $ 0.276 | ||||
| Christopher Diamantis [Member] | ||||||
| Advances from director | $ 3,600,000 | $ 3,600,000 | ||||
| Accrued and unpaid interest | $ 500,000 | $ 500,000 | $ 500,000 | |||
| Dent instrument interest rate | 10.00% | 10.00% | ||||
| Debt instrument face value | $ 500,000 | |||||
| Warrants to purchase common stock | 27,667 | |||||
| Exercise price of warrants | $ 15.00 | |||||
| Alcimede [Member] | ||||||
| Consulting fee | $ 100,000 | $ 100,000 | ||||
| Monarch Capital LLC [Member] | ||||||
| Consulting fee | $ 100,000 | |||||
| Debt instrument maturity date | Aug. 31, 2017 | |||||
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Increase for accrued, but unpaid interest on the debt instrument for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|